Choline Fenofibrate Patent Expiration

Choline Fenofibrate was first introduced by Abbvie Inc in its drug Trilipix on Dec 15, 2008. 13 different companies have introduced drugs containing Choline Fenofibrate.


Choline Fenofibrate Patents

Given below is the list of patents protecting Choline Fenofibrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Trilipix US7259186 Salts of fenofibric acid and pharmaceutical formulations thereof Jan 07, 2025

(Expired)

Abbvie



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Choline Fenofibrate's patents.

Given below is the list recent legal activities going on the following patents of Choline Fenofibrate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 16 Jan, 2019 US7259186
Recordation of Patent Grant Mailed 21 Aug, 2007 US7259186
Patent Issue Date Used in PTA Calculation 21 Aug, 2007 US7259186
Issue Notification Mailed 01 Aug, 2007 US7259186
Application Is Considered Ready for Issue 21 Jun, 2007 US7259186
Dispatch to FDC 21 Jun, 2007 US7259186
Issue Fee Payment Verified 19 Jun, 2007 US7259186
Issue Fee Payment Received 19 Jun, 2007 US7259186
Electronic Review 13 Jun, 2007 US7259186
Email Notification 12 Jun, 2007 US7259186


Choline Fenofibrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Choline Fenofibrate Generic API Manufacturers

Several generic applications have been filed for Choline Fenofibrate. The first generic version for Choline Fenofibrate was by Norvium Bioscience Llc and was approved on Mar 25, 2013. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Feb 8, 2024.

Given below is the list of companies who have filed for Choline Fenofibrate generic, along with the locations of their manufacturing plants worldwide.